Zobrazeno 1 - 10
of 116
pro vyhledávání: '"A Pouryasin"'
Publikováno v:
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, Vol 5, Iss 2, Pp 39-44 (2011)
Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity. However the most important
Externí odkaz:
https://doaj.org/article/a4d0180dc791475aa95be060bb21ac18
Autor:
Mohammad Pouryasin, Azam-Sadat Mousavi, Jalil Pakravesh, Delaram Zare Kamel, Shahla Nooriardabili, Shakiba Khodadad, Soheila Aminimoghaddam, Mehran Ghazimoghadam, Yasaman Farbod, Ali Pouryasin
Publikováno v:
Journal of Obstetrics, Gynecology and Cancer Research. 7:405-413
Autor:
Azam-Sadat Mousavi, Setareh Akhavan, Fareideh Sabzi shahrbabaki, Narges Izadi-mood, Fariba Yarandi, Mehran Ghazimoghadam, Mohammad Pouryasin, Saina Nassiri, Mamak Shariat, Ali Pouryasin
Publikováno v:
Journal of Obstetrics, Gynecology and Cancer Research. 7:151-157
Publikováno v:
BioImpacts, Vol 10, Iss 4, Pp 235-242 (2020)
BioImpacts : BI
BioImpacts : BI
Introduction: Cervical cancer is the most common female cancer in large areas of the developing world, and almost half of these cases (54%) arises in Asia, where cervical cancer is still threatening women’s health and survival, which makes it a con
Publikováno v:
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, Vol 5, Iss 2, Pp 39-44 (2011)
Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity. However the most important
Externí odkaz:
https://doaj.org/article/2a29ab7810494ce09a537a4180fb5e07
Autor:
Fariba Yarandi, Shakiba Khodadad, Mohammad Pouryasin, Ali Pouryasin, Azamsadat Mousavi, Abbas Alipour, Leila Pirzadeh
Publikováno v:
Iranian Journal of Public Health, Vol 49, Iss 9 (2020)
Iranian Journal of Public Health
Iranian Journal of Public Health
Background: Human papillomavirus (HPV) has been found as the most considerable causes of cervical cancer. Recently, several molecular methods have been introduced to increase the accuracy of the screening programs and decrease the mortality rate. Amo
Autor:
Pouryasin, Mohammad1,2,3, Keshvari, Maryam4, Sharafi, Heidar1,2,5, Alavian, Seyed Moayed1,5, Behnava, Bita1,5, Alavian, Seyed Ehsan1,5, Pouryasin, Ali2,6 ali.pouryasin@iaua.ac.ir
Publikováno v:
Hepatitis Monthly. Feb2016, Vol. 16 Issue 2, p1-9. 9p.
Autor:
Ali Pouryasin, Mohammad Pouryasin, Seyed Moayed Alavian, Maryam Keshvari, Bita Behnava, Heidar Sharafi
Publikováno v:
Laboratory Medicine. 48:51-56
Background: The IFNL4 rs368234815 polymorphism plays a prominent role in spontaneous and treatment-induced clearance of hepatitis C virus (HCV) infection. This study aimed to develop a polymerase chain reaction–restriction fragment length polymorph
Publikováno v:
Journal of Research in Medical Sciences, Vol 21, Iss 1, Pp 72-72 (2016)
Background: A dinucleotide variant rs368234815 in interferon lambda 4 (IFNL4) gene was recently found to be associated with the hepatitis C virus (HCV) treatment response. This study aimed to assess the impact of IFNL4 rs368234815 polymorphism on tre
Externí odkaz:
https://doaj.org/article/559d6f75ea4341da8ed3f79ca5925503
Autor:
Heidar Sharafi, Seyed Ehsan Alavian, Ali Pouryasin, Seyed Moayed Alavian, Mohammad Pouryasin, Paniz Shirmast, Bita Behnava, Maryam Keshvari
Publikováno v:
Journal of clinical laboratory analysis. 32(7)
Background Inosine triphosphate pyrophosphatase (ITPA) gene single nucleotide polymorphisms (SNPs), rs1127354 and rs7270101, may cause a functional impairment in ITPase enzyme, resulting anemia protection in patients with chronic hepatitis C virus (H